Effect of Aerobic Training on Sleep Problems and Pulmonary Functions in Children With Down Syndrome
1 other identifier
interventional
30
1 country
1
Brief Summary
The study will be conducted to determine the effect of aerobic training on sleep problems and pulmonary functions in children with Down syndrome.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Aug 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 5, 2023
CompletedFirst Posted
Study publicly available on registry
May 16, 2023
CompletedStudy Start
First participant enrolled
August 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
May 31, 2024
CompletedJune 4, 2025
June 1, 2025
8 months
April 5, 2023
June 1, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Sleep Problems:
Will be measured by the Arabic version of the Children's Sleep Habits Questionnaire (CSHQ): A 33-item retrospective parent-report questionnaire was created as a screening tool for sleep issues over a "typical" recent week. Each item is scored 1-3 (1 = Rarely, 0-1x/week; 2 = Sometimes, 2-4x/week; 3 = Usually, 5-7x/week). There are 6 questions with reverse scoring in order to consistently make a higher score indicative of more disrupted sleep. This will yield a total score between 33 and 99. A total score of 41 or higher suggests the presence of a sleep disturbance.
6 months
Secondary Outcomes (4)
Forced Vital Capacity (FVC):
6 months
Forced Expiratory Volume in 1 second (FEV1):
6 months
FEV1/FVC ratio:
6 months
Peak Expiratory Flow Rate (PEFR):
6 months
Study Arms (2)
Control Group
ACTIVE COMPARATORPatients will receive a selected physical therapy program only.
Study Group
EXPERIMENTALPatients will receive the same selected physical therapy program as the control group in addition to aerobic exercise in the form of treadmill training.
Interventions
Patients will receive a selected physical therapy program for 1 hr, 3 times per week, for 3 successive months in the form of: * Balance and postural control exercises for 15 minutes, including the following: * Standing on balance board. * Stoop and recovery. * Gait training for 45 minutes, including the following: * Forward, backward, and sideways walking. * Walking with obstacles using wedges and rolls with different diameters and heights.
Patients will receive the same selected physical therapy program as the control group for 15 minutes in addition to treadmill training for 45 minutes, 3 times per week, for 3 successive months. Treadmill training: Will be practiced according to the following stages: A- Warm up: 5 minutes. B- The exercise phase: 35 minutes (three-minute stages), the speed will be increased gradually every 3 minutes intervals until the child no longer be able to walk at the current stage. C- Cool down: 5 minutes.
Eligibility Criteria
You may qualify if:
- Children with Down syndrome (trisomy 21).
- Their ages range from 7 to 12 years old.
- Both sexes will be included.
- Children should be able to understand and follow simple verbal commands or instructions (intelligence quotient (IQ) range: 50-70).
- Children should be able to walk independently.
- Their total scores on the Arabic version of the Children's Sleep Habits Questionnaire (CSHQ) equal 41 or higher.
You may not qualify if:
- Children will be excluded from the study if they:
- Have visual or hearing defects.
- Have spinal abnormality such as kyphosis and scoliosis.
- Have history of pulmonary infection and surgery of thoracic and abdominal region within the past 6 months.
- Play any specific sport or exercises.
- Have physical activity restrictions.
- Have musculoskeletal disorder.
- Take medications known to affect sleep.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
Study Sites (1)
Cairo University
Cairo, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Naglaa A Zaky, PhD
Professor of Physical Therapy for Pediatrics, Faculty of Physical Therapy, Cairo University
- PRINCIPAL INVESTIGATOR
Saly S Abd Elhady, PhD
Lecturer of Physical Therapy for Pediatrics, Faculty of Physical Therapy, Cairo University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Physiotherapy Practitioner
Study Record Dates
First Submitted
April 5, 2023
First Posted
May 16, 2023
Study Start
August 1, 2023
Primary Completion
March 31, 2024
Study Completion
May 31, 2024
Last Updated
June 4, 2025
Record last verified: 2025-06